Browse Arkansas Code titles and sections
20-16-2205. Exceptions. [Effective January 1, 2020.]
Arkansas Code — all titles (historical 2020) · legal_authorities
20-16-2205. Exceptions. [Effective January 1, 2020.]
This subchapter does not restrict the funding of areas of scientific research not specifically prohibited by this subchapter, including without limitation:
(1) In vitro fertilization and accompanying embryo transfer to the body of a woman;
(2) Administration of fertility-enhancing drugs;
(3) Research in the use of nuclear transfer or other cloning techniques to produce molecules, deoxyribonucleic acid, cells other than human embryos, tissues, organs, plants, or animals other than humans; and
(4) Any diagnostic procedure that benefits the human embryo subject to destructive tests while not imposing risks greater than those considered acceptable for other human research subjects.
Source: Arkansas Code — historical release 78 (November 6, 2020) · 20-16-2205
Stored review status: Historical 2020-11-06 source release; later amendments not reconciled; machine-extracted, not independently legally reviewed; source heading status: text_in_historical_source. A text match is a research starting point; applicability is not established.
Issuing source page ↗
Authority boundary: historical statutory source snapshot not current law.
Open the recorded source website ↗
Record provenance
Stable record: arkansas_code:legal_authorities:20-16-2205
Source file: gov.ar.code.title.20.odt
Pages: Not recorded – Not recorded
Passage SHA-256: b70025092aae4bd8d05ea182735e415a9c636662612480ed38c48427ff82d24c
Source location: content.xml paragraph 14833
Stored source content
20-16-2205. Exceptions. [Effective January 1, 2020.]
This subchapter does not restrict the funding of areas of scientific research not specifically prohibited by this subchapter, including without limitation:
(1) In vitro fertilization and accompanying embryo transfer to the body of a woman;
(2) Administration of fertility-enhancing drugs;
(3) Research in the use of nuclear transfer or other cloning techniques to produce molecules, deoxyribonucleic acid, cells other than human embryos, tissues, organs, plants, or animals other than humans; and
(4) Any diagnostic procedure that benefits the human embryo subject to destructive tests while not imposing risks greater than those considered acceptable for other human research subjects.
Cross-references
Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.
No explicit source connection was found. This does not mean there are no relevant authorities.